Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?

Nicholas G. Zaorsky, Laura A. Doyle, Mark D. Hurwitz, Adam P. Dicker, Robert B. Den

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?'. Together they form a unique fingerprint.

Medicine & Life Sciences